The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
19 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,674,498 in first-year total cost, median $243,000.
Most frequent study sections
- Special Emphasis Panel[ZAI1 BDP-I (M1)]3
- Special Emphasis Panel[ZAI1 BLG-M (M2)]2
- Special Emphasis Panel[ZAI1 PA-I (S1)]2
- Special Emphasis Panel[ZAI1 QV-I (M1)]2
- Special Emphasis Panel[ZAI1 FDS-M (J1)]1
Most frequent institutions
- UNIVERSITY OF VIRGINIA3
- DUKE UNIVERSITY2
- JOHNS HOPKINS UNIVERSITY2
- MASSACHUSETTS GENERAL HOSPITAL2
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab1R34AI125058-01 | MADSEN, JOREN C | MASSACHUSETTS GENERAL HOSPITAL, MA | $293,025 | ZAI1 |
| 2016 | Planning for the Metformin for TB/HIV Host-directed Therapy (METHOD) Trial1R34AI124826-01 | KORNFELD, HARDY | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $253,930 | ZAI1 |
| 2016 | Phase II trial of extended release exenatide (Bydureon) and teplizumab in patients with new onset Type 1 Diabetes.1R34AI120909-01A1 | HEROLD, KEVAN C | YALE UNIVERSITY, CT | $251,250 | ZAI1 |
| 2016 | Epitope mismatch and medication nonadherence1R34AI118416-01A1 | MATAS, ARTHUR J | UNIVERSITY OF MINNESOTA, MN | $245,238 | ZAI1 |
| 2016 | HOPE in Action: HIV-to-HIV Solid Organ Transplantation in the US1R34AI123023-01 | DURAND, CHRISTINE MARIE | JOHNS HOPKINS UNIVERSITY, MD | $243,000 | ZAI1 |
| 2016 | Optimizing treatment for E. faecalis infective endocarditis: ampicillin plus ceftriaxone versus ampicillin plus gentamicin1R34AI122958-01 | CHU, VIVIAN H | DUKE UNIVERSITY, NC | $238,500 | ZAI1 |
| 2016 | A Phase I/II Trial of the Safety, Tolerability and Immunogenicity of a Live Attenuated Tetravalent Dengue Virus Vaccine in Adults in Dengue-Endemic Bangladesh1R34AI120917-01 | KIRKPATRICK, BETH DIANE | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $233,979 | ZAI1 |
| 2016 | Oxfendazole as a Broad Spectrum Deworming Medicine in Humans: Phase II Efficacy Study in Geohelminths1R34AI124954-01 | GILMAN, ROBERT H | JOHNS HOPKINS UNIVERSITY, MD | $233,227 | ZAI1 |
| 2016 | Dendritic Cell (DCreg) Therapy in Live Donor Renal Transplant Recipients1R34AI123033-01 | THOMSON, ANGUS W | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $231,188 | ZAI1 |
| 2015 | Effectiveness, Safety and Value of Integrating Molecular Diagnostics into the Post-Transplant Management of Kidney Transplant Recipients - The Next Frontier of Biomarker Research1R34AI118493-01 | ABECASSIS, MICHAEL M | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $279,770 | ZAI1 |
| 2015 | Cellular Therapy with Allospecific Tregs in Liver Transplantation1R34AI116394-01 | TURKA, LAURENCE A | MASSACHUSETTS GENERAL HOSPITAL, MA | $279,711 | ZAI1 |
| 2015 | Efficacy of Antiviral Suppression Therapy after Neonatal HSV Infection of the CNS1R34AI108512-01A1 | SMITH, PHILLIP BRIAN | DUKE UNIVERSITY, NC | $249,780 | ZAI1 |
| 2015 | Planning for Experimental Infection Trial to Test Hookworm Vaccine Efficacy1R34AI118537-01 | DIEMERT, DAVID JOSEPH | GEORGE WASHINGTON UNIVERSITY, DC | $161,031 | ZAI1 |
| 2014 | GLILD in CVID1R34AI106570-01A1 | BONILLA, FRACISCO ACUNNINGHAM-RUNDLES, CHARLOTTEGEHA, RAIF SALIMGUNDLING, KATHERNE EKELLY, MICHAEL EKOTH, LAURA LKOVALSZKI, ANNARAWLINGS, DAVID JROUTES, JOHN MICHAELSIMPSON, PIPPA MTORGERSON, TROY RVERBSKY, JAMES W | MEDICAL COLLEGE OF WISCONSIN, WI | $279,802 | ZAI1 |
| 2014 | Mesenchymal Stem Cell Therapy for Active Systemic Lupus Erythematosus1R34AI114453-01 | GILKESON, GARY SKAMEN, DIANE L | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $255,067 | ZAI1 |
| 2014 | Reduced Injectable, Short-course for (E)Xpert MDR-TB [RISE trial]1R34AI112371-01 | HEYSELL, SCOTT KHOUPT, ERIC R | UNIVERSITY OF VIRGINIA, VA | $241,000 | ZAI1 |
| 2014 | Effects of alanyl-glutamine supplementation on C. difficile associated diarrhea1R34AI110382-01 | WARREN, CIRLE ALCANTARA | UNIVERSITY OF VIRGINIA, VA | $237,000 | ZAI1 |
| 2014 | SIS Study of Aggressive versus Conservative Antimicrobial Initiation in the ICU1R34AI112364-01 | SAWYER, ROBERT G | UNIVERSITY OF VIRGINIA, VA | $237,000 | ZAI1 |
| 2014 | Cadaveric Donor Lung And Bone Marrow Transplantation in Immunodeficiency Diseases1R34AI110416-01 | SZABOLCS, PAUL | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $231,000 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.